| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/20/2010 | US7700830 Bacillus thuringiensis insecticidal proteins |
| 04/20/2010 | US7700758 Preparing library of heterogenous small interfering RNA sequences (HSIRNA) for use in gene expression inhibition and mammalian therapeutics; gene therapy |
| 04/20/2010 | US7700755 cytotoxins; host cells; vaccines; histology |
| 04/20/2010 | US7700749 Nucleic acid and corresponding protein entitled 205P1B5 useful in treatment and detection of cancer |
| 04/20/2010 | US7700748 VMGLOM gene and its mutations causing disorders with a vascular component |
| 04/20/2010 | US7700742 Antibodies to insulin-like growth factor I receptor |
| 04/20/2010 | US7700737 heat shock proteins (Hsp70); metastatic neoplastic diseases, sarcomas, and carcinomas; humanizing, chimeric; monoclonal antibodies, hybridomas; inhibits natural killer cells |
| 04/20/2010 | US7700736 PRO350 antibodies |
| 04/20/2010 | US7700733 Factor VII or VIIa polypeptide variants |
| 04/20/2010 | US7700719 Mutant protofibril for active immunisation; synuclein genes, proteins; point mutations; Parkinson's disease; dementia; host cells |
| 04/20/2010 | US7700571 Compositions and methods for liver growth and liver protection |
| 04/20/2010 | US7700558 Methods for treating diabetes using fibroblast growth factor-like polypeptides |
| 04/20/2010 | US7700557 for treating diseases relating to angiogenesis; fusion protein possesses ribosome inactivating activity and ability to bind to cellular vascular endothelial growth factor (VEGF) receptors |
| 04/20/2010 | US7700556 Extracellular domain of CTLA4, with (a) methionine at position 27 and ending with aspartic acid at position 150 (b) an alanine at position 26 and ending with aspartic acid at position 150 ; binds CD80 and/or CD86 with greater avidity; lupus, lupus erythematosus, and lupus nephritis |
| 04/20/2010 | US7700554 Compositions for modulating blood-brain barrier transport |
| 04/20/2010 | US7700358 Transformed microorganism comprising an isolated fragment of DNA derived from coffee and integrated into the genome or plasmid of the mannase; involved in the hydrolysis of polysaccharides |
| 04/20/2010 | US7700356 System for gene targeting and producing stable genomic transgene insertions |
| 04/20/2010 | US7700355 Methods of producing a porous matrix for culturing and recovering cells |
| 04/20/2010 | US7700354 Rapidly screening for primitive hematopoietic cells; for use in transplantation and regenerative medicine; tissue engineering |
| 04/20/2010 | US7700353 Compositions and methods for inducing apoptosis in tumor cells |
| 04/20/2010 | US7700352 proliferate or establish undifferentiated pluripotent stem cells that retain their differentiation potency by culturing pluripotent stem cells in a medium free of a feeder cell, or a serum; inhibitor of an adenylate cyclase |
| 04/20/2010 | US7700351 Methods and compositions for tissue regeneration |
| 04/20/2010 | US7700342 Lentiviral packaging constructs |
| 04/20/2010 | US7700341 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 04/20/2010 | US7700339 Echinoderm Microtubule-Associated Protein-Like 4 (EML-4); Anaplastic Lymphoma Kinase (ALK); non-small cell lung carcinoma (NSCLC) |
| 04/20/2010 | US7700324 identifying a methylated CpG containing nucleic acid by contacting a nucleic acid with a methylation sensitive restriction endonuclease that cleaves unmethylated CpG sites and contacting the sample with an isoschizomer of the methylation sensitive restriction endonuclease; determining the DNA methylation |
| 04/20/2010 | US7700318 polypeptide comprising a TNF neutralizer domain, an IL-1 receptor antagonist domain, and a dimerization domain; rheumatoid arthritis or psoriasis |
| 04/20/2010 | US7700317 glycoprotein comprising the extracellular domain of a non-naturally occurring BAFF-R; BAFF (B-cell-activating factor of the TNF family); immunologic, autoimmune diseases, cancers, virus-associated diseases, renal, hypertensive diseases, conditions requiring immunosuppression, inflammation |
| 04/20/2010 | US7700315 Comprises nucleotide sequences coding polypeptide with serine protease activity for use in identifying modulator and treaments for blood coagulation and cell proliferative disorders |
| 04/20/2010 | US7700304 inhibiting formation of neurofibrillary tangles by reducing formation of a carboxyl-terminal truncated form of apolipoprotein E (apoE) in a neuron in the individual; animal models of Alzheimer's disease (AD); treating AD; drug screening |
| 04/20/2010 | US7700297 Artery- and vein-specific proteins and uses therefor |
| 04/20/2010 | US7700284 kits that utilize a polynucleotide reporter system to detect activities of multiple trans-acting factors, such as nuclear hormone receptors and transcription factors in biological systems |
| 04/20/2010 | US7700274 Compositions and methods in cancer associated with altered expression of KCNJ9 |
| 04/20/2010 | US7700271 Method of diagnosis and treatment and agents useful for same |
| 04/20/2010 | US7700139 feeding the animal a wheat product with increased levels of resistant starch or a high relative amylose content that provide for improved bowel health; reduced level of SBEIIa enzyme activity relative to wild-type grain, amylopectin with a proportion of 4-12 dp chain length fraction of 49.99% or less |
| 04/20/2010 | US7700117 Camp factor of Streptococcus uberis |
| 04/20/2010 | US7700114 original codons are exchanged by codons which lead to an enhanced translation in a mammalian cell, contain a deletion resulting in the production of a truncated non-functional protein; capable of enhancing the immunogenicity |
| 04/20/2010 | US7700090 Co-culture of placental stem cells and stem cells from a second source |
| 04/20/2010 | US7700088 Interleukin-9 mutein peptides |
| 04/20/2010 | CA2644091A1 Embryo culture media containing thyroid hormone |
| 04/20/2010 | CA2476439C Container with at least one electrode |
| 04/20/2010 | CA2465173C Endothelial cells derived from primate embryonic stem cells |
| 04/20/2010 | CA2380943C Mechanically elongated neuronal cells and methods for producing and using these cells |
| 04/20/2010 | CA2332701C Medium and matrix for long-term proliferation of cells |
| 04/20/2010 | CA2318486C Novel nucleic acid molecules correlated with the rhesus weak d phenotype |
| 04/20/2010 | CA2219876C Stable variant hk2 polypeptide |
| 04/20/2010 | CA2212702C Mucosal vascular addressins and uses thereof |
| 04/20/2010 | CA2200496C Genetic transformation using a parp inhibitor |
| 04/20/2010 | CA2181433C Materials and methods for management of hyperacute rejection in human xenotransplantation |
| 04/20/2010 | CA2134756C Selectin variants |
| 04/20/2010 | CA2112373C Genetic sequences encoding flavonoid pathway enzymes and uses therefor |
| 04/20/2010 | CA2099562C Expression of active human protein c in mammary tissue of transgenic animals |
| 04/15/2010 | WO2010042891A2 Method for inducing pluripotency in cells |
| 04/15/2010 | WO2010042800A1 Methods of reprogramming somatic cells and methods of use for such cells |
| 04/15/2010 | WO2010042799A2 Novel chimeric ligand-gated ion channels and methods of use thereof |
| 04/15/2010 | WO2010042669A2 Co-culture compositions and methods |
| 04/15/2010 | WO2010042654A2 Recombinant nell protein production |
| 04/15/2010 | WO2010042575A1 Transgenic plants with enhanced agronomic traits |
| 04/15/2010 | WO2010042551A2 Methods for providing cellular lysates from cell wall-containing samples |
| 04/15/2010 | WO2010042490A1 A single lentiviral vector system for induced pluripotent (ips) stem cells derivation |
| 04/15/2010 | WO2010042189A2 Engineered cells expressing multiple immunomodulators and uses thereof |
| 04/15/2010 | WO2010042072A1 Apparatus for culturing anchorage dependent cells |
| 04/15/2010 | WO2010041863A2 Media composition for adipocyte differentiation |
| 04/15/2010 | WO2010041759A1 Petal-specific promoter and use thereof |
| 04/15/2010 | WO2010041715A1 Novel fructosyl peptide oxidase |
| 04/15/2010 | WO2010041617A1 Fusion protein composed of matrix metalloproteinase-2 inhibitor peptide derived from amyloid-β precursor protein and tissue inhibitor of metalloproteinase-2 |
| 04/15/2010 | WO2010041419A1 Novel protein having fructosyl valyl histidine oxidase activity and modified product thereof, and use of the protein or the modified product |
| 04/15/2010 | WO2010040920A2 Device for cell culture |
| 04/15/2010 | WO2010040901A1 Alternative oxidase and uses thereof |
| 04/15/2010 | WO2010040885A1 Dual cellular model of cancer |
| 04/15/2010 | WO2010040882A1 Oncostatin m as promoter of immunostimulatory activity of human epithelial cells |
| 04/15/2010 | WO2010040804A2 Methods for controlled seeding of adherent cell types on high density patterned cell cultures |
| 04/15/2010 | WO2010040699A1 Multi-culture bioreactor system |
| 04/15/2010 | WO2010040526A1 Lcmv-gp-vsv-pseudotyped vectors and tumor-infiltrating virus-producing cells for the therapy of tumors |
| 04/15/2010 | WO2010040302A1 Methods for isolating mesenchymal stem cells from embryos of human or animals and extracting secretion substances thereof |
| 04/15/2010 | WO2010040262A1 Methods for isolating animal embryonic mesenchymal stem cells and extracting secretion substance thereof |
| 04/15/2010 | WO2010022194A3 Compositions and methods for generation of pluripotent stem cells |
| 04/15/2010 | WO2010020876A3 Cell culture method to form aggregates |
| 04/15/2010 | WO2010016083A8 Use of isolated mature adipocytes in regenerative medicine for the reconstruction and reparation of tissues |
| 04/15/2010 | WO2009151907A3 Compositions and methods for using cells to treat heart tissue |
| 04/15/2010 | WO2009150051A9 Biocompatible materials for mammalian stem cell growth and differentiation |
| 04/15/2010 | WO2009143412A3 Polymeric systems containing intracellular releasable disulfide linker for the delivery of oligonucleotides |
| 04/15/2010 | WO2009134670A3 New chimeric alpha-amylase variants |
| 04/15/2010 | WO2009120357A8 De novo anembryonic trophoblast vesicles and methods of making and using them |
| 04/15/2010 | WO2009105570A3 Methods, surface modified plates and compositions for cell attachment, cultivation and detachment |
| 04/15/2010 | WO2009080299A8 Sm-protein based secretion engineering |
| 04/15/2010 | US20100095402 Materials and methods for engineering resistance to tomato yellow leaf curl virus (tylcv) in plants, |
| 04/15/2010 | US20100095399 Protein for use in modifying abiotic stress tolerance in yeast |
| 04/15/2010 | US20100095398 Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors |
| 04/15/2010 | US20100095397 Polynucleotides and methods for the improvement of plants |
| 04/15/2010 | US20100095392 Rice Hybrid XL745 |
| 04/15/2010 | US20100095390 Aldolases, Nucleic Acids Encoding Them and Methods for Making and Using Them |
| 04/15/2010 | US20100093842 Laulimalide Analogs and Uses Thereof |
| 04/15/2010 | US20100093840 Human Sef isoforms and methods of using same for cancer diagnosis and gene therapy |
| 04/15/2010 | US20100093839 hypoxia-inducible factor-1 alpha (HIP-1 alpha); nucleosides, Locked Nucleic Acids; treating kidney cancer, melanoma, glioblastoma and prostate cancer, and pre-eclampsia |
| 04/15/2010 | US20100093836 Compounds and methods for modulating protein expression |
| 04/15/2010 | US20100093834 Manipulation of neuronal ion channels |
| 04/15/2010 | US20100093833 Methods for Inducing Differentiation of Undifferentiated Mammalian Cells Into Osteoblasts |
| 04/15/2010 | US20100093831 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
| 04/15/2010 | US20100093830 Modulation of MLCK-L Expression and Uses Thereof |